Press release
Tardive Dyskinesia (TD) Treatment Drugs Market Is Expanding At CAGR Of 3.7% From 2018 To 2026 - Credence Research
Browse the full report Tardive Dyskinesia (TD) Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026 report at http://www.credenceresearch.com/report/tardive-dyskinesia-td-treatment-drugs-market
Market Insights
Tardive dyskinesia (TD) treatment drugs market is expected to show significant market growth over the forecast period due to increase in incidence of TD, rising number of antipsychotic prescriptions, developing healthcare infrastructure and presence of late stage pipeline molecule. The global TD treatment drugs market is categorized on the basis of drug type such as valbenazine, deutetrabenazine and others (benzodiazepines, botulinum toxin, vitamin E, amantadine, levodopa, reserpine, dopamine-depleting agents and calcium channel blockers etc.). It is observed that the demand for valbenazine and deutetrabenazine is highest in market due to the efficacy and target specificity. Valbenazine and deutetrabenazine were approved in 2017. Furthermore, being the only approved drugs in the market, these drugs will experience significant demand.
Neurocrine Biosciences announced that the recently approved, Ingrezza (valbenazine) achieved $45.8 million net sales in third quarter in 2017. Expected launch of pipeline drug such as SNC-102 (Synchroneuron) would further drive the market growth during forecast period. Currently, North America leads the global TD treatment drugs market due to higher cost of therapeutics, early diagnosis of the disease and increase in prevalence of TD. It is predicted that TD treatment drugs market in Asia Pacific will grow significantly in coming years due to growing number of affected population and emerging healthcare infrastructure.
Market Competition Assessment:
Currently, only two drugs Valbenazine by Neurocrine Biosciences, Inc. and Deutetrabenazine by Teva Pharmaceutical Industries Ltd. are approved by US-FDA for the treatment of TD. Key players involved in R&D activities are Synchroneuron Inc. (SNC-102) and Auspex Pharmaceuticals (SD–809).
Browse the full report at http://www.credenceresearch.com/report/tardive-dyskinesia-td-treatment-drugs-market
Browse More Reports From This Category @ http://www.credenceresearch.com/industry/pharmaceuticals-market
Blog @ http://www.mobilecomputingtoday.co.uk/7376/tardive-dyskinesia-treatment-drugs-market-expanding-cagr-3-7-2018-2026-credence-research/
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager
Address : 105 N 1st ST #429, SAN JOSE, CA 95103, United States
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tardive Dyskinesia (TD) Treatment Drugs Market Is Expanding At CAGR Of 3.7% From 2018 To 2026 - Credence Research here
News-ID: 906095 • Views: …
More Releases from Credence Research Inc
Chemical-synthesizer-market to Reach USD 3,375 million by 2032 at 7.6% CAGR - Cr …
Market Overview:
The Chemical Synthesizer Market size was valued at USD 2,525 million in 2024 and is anticipated to reach USD 3,375 million, at a CAGR of 7.6% during the forecast period.
The market expands as labs move toward advanced automation to boost productivity and cut manual steps. Researchers prefer systems that support multi-step reactions with tight control over temperature, pressure, and purification. Rising drug discovery activity, growing material science studies,…
AB Testing Software Market Projected to Hit USD 25816.9 Million by 2032, Expandi …
Market Outlook
The AB Testing Software Market is set for strong expansion as digital brands increase their focus on data-driven optimization. The market was valued at USD 8,180 million in 2024 and is projected to reach USD 25,816.9 million by 2032, advancing at a CAGR of 15.45%. Growth accelerates as enterprises adopt experimentation platforms to refine user experience, improve conversions, and strengthen product decisions. Rising digital traffic, rapid adoption of AI-powered…
Global Cryptocurrency Mining ASIC Market to Reach USD 19,621.87 million by 2032 …
Market Overview
The Global Cryptocurrency Mining ASIC Market size was valued at USD 8,904.56 million in 2024 and is anticipated to reach USD 19,621.87 million by 2032, at a CAGR of 9.67% during the forecast period.
Demand rises as miners seek faster hash rates with lower power use. Many operators replace older rigs to reduce energy waste and protect profit margins. Hardware makers introduce improved chips that support stable uptime…
Packaging Solution Market Projected to Hit USD 1,895,431 Million by 2032, Expand …
Market Outlook
The Packaging Solution Market is set for steady expansion as global demand rises across food, pharmaceutical, personal care, and industrial sectors. The market reached USD 1,302,620 million in 2024 and is projected to achieve USD 1,895,431 million by 2032, driven by a CAGR of 4.8% during the forecast period. Strong growth comes from higher consumption of packaged goods, rising e-commerce shipments, and the shift toward sustainable and lightweight materials.…
More Releases for Tardive
Tardive Dyskinesia Treatment Market Analysis By Drug Class & Distribution Channe …
The Tardive Dyskinesia Treatment Market is expected to Reach a CAGR of 4% during the forecast period (2024-2031).
Tardive Dyskinesia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Tardive Dyskinesia Market Report and Forecast 2024-2032
The tardive dyskinesia market size is anticipated to grow at a CAGR of 3.2 % during the forecast period of 2024-2032, driven by growing awareness about the importance of monitoring patients on long-term antipsychotic therapy for early signs of tardive dyskinesia in the major markets.
Tardive Dyskinesia: Introduction
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. It primarily affects the face, causing grimacing, blinking, or lip-smacking, but can…
Global Tardive Dyskinesia (TD) Treatment Market - Opportunities & Forecasts, 202 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global tardive dyskinesia (td) treatment market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to…
Tardive Dyskinesia Drugs Market Competitor Landscape, Opportunity Analysis, Grow …
Tardive neurological disorder (TD) may be a kind of dyskinesia that's tough to treat. it's a nerve disorder characterised by involuntary movements like jaw, lips, and tongue, thought-about as grimacing, protrusive the tongue out, and lip smack. another symptoms square measure a private experiencing involuntary movement of the lower and higher extremities and additionally respiratory choking.
Get HOLISTIC Request Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/218
consistent with Center for Drug analysis and analysis, dyskinesia will…
Tardive Dyskinesia (TD) Treatment Drugs Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Tardive Dyskinesia (TD) Treatment Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Tardive Dyskinesia (TD) Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$…
Antioxidants May Aid in the Treatment of Tardive Dyskinesia
Memphis, TN (May 9, 2019) – Today, The Primary Care Companion for CNS Disorders published a case report on the use of antioxidants in the treatment of tardive dyskinesia. While new pharmacologic discoveries have occurred in the area of movement disorders, their use comes with a large price tag. Thus, for mild cases, clinicians may want to seek out more cost-effective options. Antioxidants may serve a role in the prevention…
